Casi Pharmaceuticals Historical Balance Sheet

CASI
 Stock
  

USD 1.97  0.02  1.03%   

Trend analysis of Casi Pharmaceuticals balance sheet accounts such as Receivables of 10.6 M, Accounts Payable of 5.2 M or Accumulated Other Comprehensive Income of 2.1 M provides information on Casi Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Casi Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Casi Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Casi Pharmaceuticals prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Casi Pharmaceuticals is a good buy for the upcoming year.
Continue to Trending Equities.
  

About Casi Pharmaceuticals Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Casi Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Casi Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Casi Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Casi Pharmaceuticals currently owns. An asset can also be divided into two categories, current and non-current.

Casi Pharmaceuticals Balance Sheet Chart

Casi Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Casi Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
Casi Pharmaceuticals Accumulated Other Comprehensive Income is most likely to increase significantly in the upcoming years. The last year's value of Accumulated Other Comprehensive Income was reported at 1.95 Million. The current Total Assets is estimated to increase to about 149.2 M, while Cash and Equivalents is projected to decrease to roughly 32.6 M.

Total Assets

Total assets refers to the total amount of Casi Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Casi Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; Goodwill and Intangible Assets; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Casi Pharmaceuticals include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Casi Pharmaceuticals. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Casi Pharmaceuticals balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Casi Pharmaceuticals books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Casi Pharmaceuticals balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Casi Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Casi Pharmaceuticals Accumulated Other Comprehensive Income is most likely to increase significantly in the upcoming years. The last year's value of Accumulated Other Comprehensive Income was reported at 1.95 Million. The current Total Assets is estimated to increase to about 149.2 M, while Cash and Equivalents is projected to decrease to roughly 32.6 M.
 2020 2021 2022 (projected)
Receivables4.64 M9.8 M10.58 M
Inventories1.36 M1.91 M2.51 M

Casi Pharmaceuticals balance sheet Correlations

-0.82-0.69-0.76-0.56-0.86-0.340.760.83-0.69-0.63-0.60.84-0.35-0.95-0.99-0.92-0.88-0.78-0.66-0.58-0.81-0.82
-0.820.760.740.480.90.19-0.8-0.870.90.930.59-0.810.40.910.890.960.870.90.560.660.931.0
-0.690.760.850.670.90.47-0.79-0.940.810.680.72-0.950.860.850.720.760.910.940.180.940.90.76
-0.760.740.850.930.930.77-0.64-0.860.830.650.96-0.860.640.840.770.780.850.910.10.790.860.76
-0.560.480.670.930.730.95-0.34-0.620.650.390.98-0.640.510.60.550.530.620.72-0.20.660.620.5
-0.860.90.90.930.730.48-0.85-0.970.890.830.8-0.960.660.960.890.930.960.960.40.790.980.91
-0.340.190.470.770.950.48-0.07-0.380.420.10.89-0.420.40.350.30.250.370.49-0.430.510.350.21
0.76-0.8-0.79-0.64-0.34-0.85-0.070.91-0.65-0.74-0.450.89-0.66-0.88-0.8-0.84-0.85-0.79-0.63-0.63-0.88-0.8
0.83-0.87-0.94-0.86-0.62-0.97-0.380.91-0.85-0.79-0.70.99-0.75-0.96-0.86-0.9-0.97-0.95-0.43-0.83-0.98-0.88
-0.690.90.810.830.650.890.42-0.65-0.850.910.72-0.790.50.840.770.870.860.920.250.790.920.92
-0.630.930.680.650.390.830.1-0.74-0.790.910.51-0.710.380.790.740.880.790.840.470.620.90.94
-0.60.590.720.960.980.80.89-0.45-0.70.720.51-0.710.560.680.610.610.670.79-0.110.680.710.6
0.84-0.81-0.95-0.86-0.64-0.96-0.420.890.99-0.79-0.71-0.71-0.79-0.95-0.85-0.86-0.97-0.93-0.4-0.84-0.94-0.82
-0.350.40.860.640.510.660.4-0.66-0.750.50.380.56-0.790.560.350.40.660.68-0.080.770.660.41
-0.950.910.850.840.60.960.35-0.88-0.960.840.790.68-0.950.560.970.970.970.920.580.740.950.92
-0.990.890.720.770.550.890.3-0.8-0.860.770.740.61-0.850.350.970.970.910.830.680.610.870.89
-0.920.960.760.780.530.930.25-0.84-0.90.870.880.61-0.860.40.970.970.920.890.640.660.940.97
-0.880.870.910.850.620.960.37-0.85-0.970.860.790.67-0.970.660.970.910.920.930.490.810.960.89
-0.780.90.940.910.720.960.49-0.79-0.950.920.840.79-0.930.680.920.830.890.930.270.90.970.9
-0.660.560.180.1-0.20.4-0.43-0.63-0.430.250.47-0.11-0.4-0.080.580.680.640.490.270.00.430.55
-0.580.660.940.790.660.790.51-0.63-0.830.790.620.68-0.840.770.740.610.660.810.90.00.810.68
-0.810.930.90.860.620.980.35-0.88-0.980.920.90.71-0.940.660.950.870.940.960.970.430.810.94
-0.821.00.760.760.50.910.21-0.8-0.880.920.940.6-0.820.410.920.890.970.890.90.550.680.94
Click cells to compare fundamentals

Casi Pharmaceuticals Account Relationship Matchups

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Casi Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Casi Pharmaceuticals' short interest history, or implied volatility extrapolated from Casi Pharmaceuticals options trading.

Pair Trading with Casi Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Casi Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Casi Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Casi Pharmaceuticals

-0.77SGMLSigma Lithium Corp Buyout TrendPairCorr
The ability to find closely correlated positions to Casi Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Casi Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Casi Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Casi Pharmaceuticals to buy it.
The correlation of Casi Pharmaceuticals is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Casi Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Casi Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Casi Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Casi Pharmaceuticals price analysis, check to measure Casi Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Casi Pharmaceuticals is operating at the current time. Most of Casi Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Casi Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Casi Pharmaceuticals' price. Additionally, you may evaluate how the addition of Casi Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Casi Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Casi Pharmaceuticals. If investors know Casi Pharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Casi Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
26.5 M
Quarterly Revenue Growth YOY
0.26
Return On Assets
(0.15) 
Return On Equity
(0.27) 
The market value of Casi Pharmaceuticals is measured differently than its book value, which is the value of Casi Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Casi Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Casi Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Casi Pharmaceuticals' market value can be influenced by many factors that don't directly affect Casi Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Casi Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Casi Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Casi Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.